Human Gene MIR518D (ENST00000385014.3) from GENCODE V44
  Description: Homo sapiens microRNA 518d (MIR518D), microRNA. (from RefSeq NR_030211)
RefSeq Summary (NR_030211): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000385014.3
Gencode Gene: ENSG00000283330.1
Transcript (Including UTRs)
   Position: hg38 chr19:53,734,877-53,734,963 Size: 87 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksPrimersCTDMicroarray ExpressionOther Species
mRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr19:53,734,877-53,734,963)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerGencodeHGNCLynxMalacards
PubMedBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  DM004879 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM175476 - A nucleics Acid regulating cell growth.
FV527622 - Nucleic acid controling mast cell degranulation.
FW422221 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HI979158 - Sequence 85 from Patent EP2234483.
HV342540 - JP 2011510623-A/85: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HV534387 - WO 2011111715-A/903: Nucleic acid for controlling cell cycle.
HW105356 - JP 2013502906-A/53: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS.
HW368092 - JP 2012228254-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW674831 - JP 2014217381-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067773 - JP 2014012020-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408522 - JP 2015528002-A/1119: CHIRAL CONTROL.
HZ428197 - JP 2014217384-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429000 - JP 2014217385-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429803 - JP 2014217386-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430606 - JP 2014217387-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769863 - JP 2014223080-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA059257 - Sequence 759 from Patent EP2298893.
JA060060 - Sequence 759 from Patent EP2298894.
JA074383 - Sequence 759 from Patent EP2281887.
JA105520 - Sequence 759 from Patent EP2302051.
JA106860 - Sequence 759 from Patent EP2302052.
JA107663 - Sequence 759 from Patent EP2302053.
JA108466 - Sequence 759 from Patent EP2302054.
JA109269 - Sequence 759 from Patent EP2302055.
JA110072 - Sequence 759 from Patent EP2302056.
JA134474 - Sequence 46 from Patent WO2011036398.
JA171097 - Sequence 53 from Patent WO2011023413.
JA172742 - Sequence 53 from Patent WO2011023414.
JA218700 - Sequence 759 from Patent EP2281888.
JA226851 - Sequence 759 from Patent EP2292755.
JA229706 - Sequence 759 from Patent EP2292756.
JA257977 - Sequence 759 from Patent EP2284265.
JA279257 - Sequence 759 from Patent EP2281886.
JA285143 - Sequence 759 from Patent EP2281889.
JA293196 - Sequence 759 from Patent EP2287303.
JA318382 - Sequence 759 from Patent EP2314688.
JA375441 - Sequence 759 from Patent EP2322616.
JC991193 - Sequence 759 from Patent EP2808390.
LF715296 - JP 2016165292-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LG051856 - KR 1020150036642-A/1122: CHIRAL CONTROL.
AY882327 - Homo sapiens microRNA HSA-MIR-RG-94, complete sequence.
AY882336 - Homo sapiens microRNA HSA-MIR-RG-103, complete sequence.
CS548507 - Sequence 1537 from Patent EP1777301.
CS548538 - Sequence 1568 from Patent EP1777301.
DM174535 - A nucleics Acid regulating cell growth.
DM175339 - A nucleics Acid regulating cell growth.
FW312269 - DETECTING NUCLEIC ACIDS.
FW312293 - DETECTING NUCLEIC ACIDS.
FW364393 - Oligonucleotides for modulating target RNA activity.
FZ421151 - JP 2010539978-A/51: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
FZ421175 - JP 2010539978-A/75: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
HI964998 - Sequence 283 from Patent WO2010139812.
HI966451 - Sequence 771 from Patent WO2010139811.
HI967317 - Sequence 771 from Patent WO2010139810.
HV533509 - WO 2011111715-A/25: Nucleic acid for controlling cell cycle.
HV595301 - JP 2010539959-A/682: Micromirs.
HW105364 - JP 2013502906-A/61: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS.
HW502465 - JP 2014050389-A/51: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
HW502489 - JP 2014050389-A/75: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
HW818097 - JP 2015500013-A/24: Expression of miRNAs in placental tissue.
HZ074333 - JP 2013535982-A/424: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157858 - JP 2015130862-A/682: Micromirs.
HZ186706 - JP 2015146814-A/455: Oligonucleotides for modulating target RNA activity.
HZ482139 - JP 2015535430-A/2645: TERMINALLY MODIFIED RNA.
HZ792070 - JP 2016504050-A/3815: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA171105 - Sequence 61 from Patent WO2011023413.
JA172750 - Sequence 61 from Patent WO2011023414.
JA401036 - Sequence 283 from Patent WO2011080318.
JA402014 - Sequence 283 from Patent WO2011080315.
JA403021 - Sequence 283 from Patent WO2011080316.
JA405652 - Sequence 283 from Patent EP2336353.
JA427320 - Sequence 653 from Patent WO2011072177.
JA429178 - Sequence 283 from Patent WO2011095623.
JA791627 - Sequence 29 from Patent WO2012089772.
JA792033 - Sequence 82 from Patent WO2012089753.
JB620511 - Sequence 491 from Patent WO2013063544.
JB730402 - Sequence 24 from Patent WO2013079701.
JC037689 - Sequence 217 from Patent EP2643479.
JC334393 - Sequence 311 from Patent EP2487240.
JC514802 - Sequence 5055 from Patent WO2014113089.
LF160823 - JP 2016513950-A/889: Oligomers with improved off-target profile.
LP727077 - Sequence 771 from Patent EP2883966.
LP819347 - Sequence 771 from Patent EP3296406.
LP834140 - Sequence 24 from Patent EP3190186.
LP939289 - Sequence 771 from Patent EP3184651.
LQ072390 - Sequence 2714 from Patent EP2964234.
LQ278675 - Sequence 214 from Patent WO2016066288.
LY405366 - KR 1020160117535-A/671: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ234063 - JP 2017184756-A/455: Oligonucleotides for modulating target RNA activity.
MA260605 - JP 2017505623-A/671: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA267352 - JP 2018061445-A/86: Method for detecting urothelial cancer based on microRNA in urine using cell sorting.
MA645891 - JP 2017113010-A/3815: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733775 - JP 2017140048-A/2645: TERMINALLY MODIFIED RNA.
MP015076 - Sequence 279 from Patent WO2019016252.
MS834137 - Sequence 283 from Patent EP3112479.
DI443543 - KR 1020140074997-A/164: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DI443544 - KR 1020140074997-A/165: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DM175337 - A nucleics Acid regulating cell growth.
DM175343 - A nucleics Acid regulating cell growth.
FW364389 - Oligonucleotides for modulating target RNA activity.
FW364407 - Oligonucleotides for modulating target RNA activity.
FW364423 - Oligonucleotides for modulating target RNA activity.
HI964968 - Sequence 253 from Patent WO2010139812.
HI964984 - Sequence 269 from Patent WO2010139812.
HI965002 - Sequence 287 from Patent WO2010139812.
HI966103 - Sequence 423 from Patent WO2010139811.
HI966150 - Sequence 470 from Patent WO2010139811.
HI966280 - Sequence 600 from Patent WO2010139811.
HI966969 - Sequence 423 from Patent WO2010139810.
HI967016 - Sequence 470 from Patent WO2010139810.
HI967146 - Sequence 600 from Patent WO2010139810.
HI979148 - Sequence 75 from Patent EP2234483.
HV342530 - JP 2011510623-A/75: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HV533872 - WO 2011111715-A/388: Nucleic acid for controlling cell cycle.
HV533877 - WO 2011111715-A/393: Nucleic acid for controlling cell cycle.
HV533880 - WO 2011111715-A/396: Nucleic acid for controlling cell cycle.
HV595298 - JP 2010539959-A/679: Micromirs.
HV943732 - JP 2012516688-A/208: METHODS OF DETECTING SEPSIS.
HW105357 - JP 2013502906-A/54: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS.
HW105387 - JP 2013502906-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS.
HW105417 - JP 2013502906-A/114: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS.
HW105419 - JP 2013502906-A/116: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS.
HW608565 - JP 2014515024-A/54: Micro-RNA Inhibitors and Their Uses in Disease.
HW807869 - JP 2014534810-A/164: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW807870 - JP 2014534810-A/165: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW818093 - JP 2015500013-A/20: Expression of miRNAs in placental tissue.
HW818111 - JP 2015500013-A/38: Expression of miRNAs in placental tissue.
HW818127 - JP 2015500013-A/54: Expression of miRNAs in placental tissue.
HZ074337 - JP 2013535982-A/428: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157855 - JP 2015130862-A/679: Micromirs.
HZ186702 - JP 2015146814-A/451: Oligonucleotides for modulating target RNA activity.
HZ186720 - JP 2015146814-A/469: Oligonucleotides for modulating target RNA activity.
HZ186736 - JP 2015146814-A/485: Oligonucleotides for modulating target RNA activity.
HZ482135 - JP 2015535430-A/2641: TERMINALLY MODIFIED RNA.
HZ482164 - JP 2015535430-A/2670: TERMINALLY MODIFIED RNA.
HZ482180 - JP 2015535430-A/2686: TERMINALLY MODIFIED RNA.
HZ792066 - JP 2016504050-A/3811: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
HZ792095 - JP 2016504050-A/3840: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
HZ792111 - JP 2016504050-A/3856: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA171098 - Sequence 54 from Patent WO2011023413.
JA171128 - Sequence 84 from Patent WO2011023413.
JA171158 - Sequence 114 from Patent WO2011023413.
JA171160 - Sequence 116 from Patent WO2011023413.
JA172743 - Sequence 54 from Patent WO2011023414.
JA172773 - Sequence 84 from Patent WO2011023414.
JA172803 - Sequence 114 from Patent WO2011023414.
JA172805 - Sequence 116 from Patent WO2011023414.
JA401006 - Sequence 253 from Patent WO2011080318.
JA401022 - Sequence 269 from Patent WO2011080318.
JA401040 - Sequence 287 from Patent WO2011080318.
JA401984 - Sequence 253 from Patent WO2011080315.
JA402000 - Sequence 269 from Patent WO2011080315.
JA402018 - Sequence 287 from Patent WO2011080315.
JA402991 - Sequence 253 from Patent WO2011080316.
JA403007 - Sequence 269 from Patent WO2011080316.
JA403025 - Sequence 287 from Patent WO2011080316.
JA405622 - Sequence 253 from Patent EP2336353.
JA405638 - Sequence 269 from Patent EP2336353.
JA405656 - Sequence 287 from Patent EP2336353.
JA427116 - Sequence 449 from Patent WO2011072177.
JA429148 - Sequence 253 from Patent WO2011095623.
JA429164 - Sequence 269 from Patent WO2011095623.
JA429182 - Sequence 287 from Patent WO2011095623.
JA660699 - Sequence 153 from Patent WO2011131354.
JA679065 - Sequence 208 from Patent EP2391738.
JA791608 - Sequence 10 from Patent WO2012089772.
JA791662 - Sequence 64 from Patent WO2012089772.
JA791984 - Sequence 33 from Patent WO2012089753.
JA792182 - Sequence 231 from Patent WO2012089753.
JB022453 - Sequence 295 from Patent WO2013026685.
JB022496 - Sequence 338 from Patent WO2013026685.
JB023025 - Sequence 279 from Patent WO2013026684.
JB023093 - Sequence 347 from Patent WO2013026684.
JB049984 - Sequence 71 from Patent WO2013020926.
JB050196 - Sequence 283 from Patent WO2013020926.
JB158066 - Sequence 54 from Patent WO2012142313.
JB620515 - Sequence 495 from Patent WO2013063544.
JB620516 - Sequence 496 from Patent WO2013063544.
JB620536 - Sequence 516 from Patent WO2013063544.
JB730398 - Sequence 20 from Patent WO2013079701.
JB730416 - Sequence 38 from Patent WO2013079701.
JB730432 - Sequence 54 from Patent WO2013079701.
JB733829 - Sequence 3232 from Patent WO2013082448.
JC514798 - Sequence 5051 from Patent WO2014113089.
JC514827 - Sequence 5080 from Patent WO2014113089.
JC514843 - Sequence 5096 from Patent WO2014113089.
JE867420 - Sequence 227 from Patent WO2015128671.
JE978708 - Sequence 153 from Patent EP2865765.
LF159947 - JP 2016513950-A/13: Oligomers with improved off-target profile.
LF160712 - JP 2016513950-A/778: Oligomers with improved off-target profile.
LF161627 - JP 2016513950-A/1693: Oligomers with improved off-target profile.
LP726729 - Sequence 423 from Patent EP2883966.
LP726776 - Sequence 470 from Patent EP2883966.
LP726906 - Sequence 600 from Patent EP2883966.
LP818999 - Sequence 423 from Patent EP3296406.
LP819046 - Sequence 470 from Patent EP3296406.
LP819176 - Sequence 600 from Patent EP3296406.
LP834136 - Sequence 20 from Patent EP3190186.
LP834154 - Sequence 38 from Patent EP3190186.
LP834170 - Sequence 54 from Patent EP3190186.
LP938941 - Sequence 423 from Patent EP3184651.
LP938988 - Sequence 470 from Patent EP3184651.
LP939118 - Sequence 600 from Patent EP3184651.
LQ072386 - Sequence 2710 from Patent EP2964234.
LQ072415 - Sequence 2739 from Patent EP2964234.
LQ072431 - Sequence 2755 from Patent EP2964234.
LQ278580 - Sequence 119 from Patent WO2016066288.
LX154579 - JP 2017509333-A/227: Biomarkers for Endometriosis.
LY405363 - KR 1020160117535-A/668: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ234059 - JP 2017184756-A/451: Oligonucleotides for modulating target RNA activity.
LZ234077 - JP 2017184756-A/469: Oligonucleotides for modulating target RNA activity.
LZ234093 - JP 2017184756-A/485: Oligonucleotides for modulating target RNA activity.
MA260602 - JP 2017505623-A/668: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA267347 - JP 2018061445-A/81: Method for detecting urothelial cancer based on microRNA in urine using cell sorting.
MA267348 - JP 2018061445-A/82: Method for detecting urothelial cancer based on microRNA in urine using cell sorting.
MA267349 - JP 2018061445-A/83: Method for detecting urothelial cancer based on microRNA in urine using cell sorting.
MA645887 - JP 2017113010-A/3811: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA645916 - JP 2017113010-A/3840: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA645932 - JP 2017113010-A/3856: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733771 - JP 2017140048-A/2641: TERMINALLY MODIFIED RNA.
MA733800 - JP 2017140048-A/2670: TERMINALLY MODIFIED RNA.
MA733816 - JP 2017140048-A/2686: TERMINALLY MODIFIED RNA.
MS673476 - Sequence 279 from Patent EP3135774.
MS673544 - Sequence 347 from Patent EP3135774.
MS834107 - Sequence 253 from Patent EP3112479.
MS834123 - Sequence 269 from Patent EP3112479.
MS834141 - Sequence 287 from Patent EP3112479.
MS901822 - Sequence 295 from Patent EP3156505.
MS901865 - Sequence 338 from Patent EP3156505.
AY882294 - Homo sapiens microRNA HSA-MIR-RG-64, complete sequence.
AY785916 - Homo sapiens microRNA hsa-RG-6, complete sequence.
CS548511 - Sequence 1541 from Patent EP1777301.
DM174527 - A nucleics Acid regulating cell growth.
FV525791 - Nucleic acid controling mast cell degranulation.
FW312266 - DETECTING NUCLEIC ACIDS.
FW364388 - Oligonucleotides for modulating target RNA activity.
HI965003 - Sequence 288 from Patent WO2010139812.
HI966432 - Sequence 752 from Patent WO2010139811.
HI967298 - Sequence 752 from Patent WO2010139810.
HI979157 - Sequence 84 from Patent EP2234483.
HV342539 - JP 2011510623-A/84: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HV595297 - JP 2010539959-A/678: Micromirs.
HW105358 - JP 2013502906-A/55: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS.
HW399363 - WO 2013179672-A/3: Diagnosis of Endometriosis.
HW669817 - JP 2013537538-A/548: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW818092 - JP 2015500013-A/19: Expression of miRNAs in placental tissue.
HW913477 - JP 2015504307-A/237: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074356 - JP 2013535982-A/447: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157854 - JP 2015130862-A/678: Micromirs.
HZ186701 - JP 2015146814-A/450: Oligonucleotides for modulating target RNA activity.
HZ482134 - JP 2015535430-A/2640: TERMINALLY MODIFIED RNA.
HZ792065 - JP 2016504050-A/3810: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA171099 - Sequence 55 from Patent WO2011023413.
JA172744 - Sequence 55 from Patent WO2011023414.
JA401041 - Sequence 288 from Patent WO2011080318.
JA402019 - Sequence 288 from Patent WO2011080315.
JA403026 - Sequence 288 from Patent WO2011080316.
JA405657 - Sequence 288 from Patent EP2336353.
JA427278 - Sequence 611 from Patent WO2011072177.
JA429183 - Sequence 288 from Patent WO2011095623.
JB022333 - Sequence 175 from Patent WO2013026685.
JB022817 - Sequence 71 from Patent WO2013026684.
JB049974 - Sequence 61 from Patent WO2013020926.
JB616262 - Sequence 92 from Patent WO2013107459.
JB620537 - Sequence 517 from Patent WO2013063544.
JB730397 - Sequence 19 from Patent WO2013079701.
JB778858 - Sequence 237 from Patent WO2013078283.
JC270157 - Sequence 548 from Patent WO2012020307.
JC334374 - Sequence 292 from Patent EP2487240.
JC514797 - Sequence 5050 from Patent WO2014113089.
JE844848 - Sequence 3 from Patent EP2857521.
LF161819 - JP 2016513950-A/1885: Oligomers with improved off-target profile.
LP727058 - Sequence 752 from Patent EP2883966.
LP819328 - Sequence 752 from Patent EP3296406.
LP834135 - Sequence 19 from Patent EP3190186.
LP939270 - Sequence 752 from Patent EP3184651.
LQ072385 - Sequence 2709 from Patent EP2964234.
LX270614 - JP 2016056210-A/548: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY405362 - KR 1020160117535-A/667: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ234058 - JP 2017184756-A/450: Oligonucleotides for modulating target RNA activity.
MA260601 - JP 2017505623-A/667: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA645886 - JP 2017113010-A/3810: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730761 - JP 2017125065-A/548: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA733770 - JP 2017140048-A/2640: TERMINALLY MODIFIED RNA.
MS637986 - Sequence 103 from Patent WO2017037190.
MS673268 - Sequence 71 from Patent EP3135774.
MS834142 - Sequence 288 from Patent EP3112479.
MS901702 - Sequence 175 from Patent EP3156505.
MA802944 - JP 2018183181-A/3815: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA802940 - JP 2018183181-A/3811: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA802969 - JP 2018183181-A/3840: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA802985 - JP 2018183181-A/3856: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA802939 - JP 2018183181-A/3810: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MB407013 - WO 2019159884-A/503: Kit, device, and method for detection of dementia.
MB407413 - WO 2019159884-A/903: Kit, device, and method for detection of dementia.
MB406615 - WO 2019159884-A/105: Kit, device, and method for detection of dementia.
MB460479 - JP 2018523696-A/8: METHODS AND COMPOSITIONS TO TREAT LIVER DISEASES AND CONDITIONS.
MB460480 - JP 2018523696-A/9: METHODS AND COMPOSITIONS TO TREAT LIVER DISEASES AND CONDITIONS.
MB460481 - JP 2018523696-A/10: METHODS AND COMPOSITIONS TO TREAT LIVER DISEASES AND CONDITIONS.

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000385014.1, ENST00000385014.2, NR_030211, uc021vao.1, uc021vao.2, uc021vao.3
UCSC ID: ENST00000385014.3
RefSeq Accession: NR_030211

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.